ZTS
Zoetis Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$73.00
+0.15%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
11.8x
EV/EBITDA
9.9x
Market Cap
$30.17B
MomentumView details →
1D Return
+0.15%
YTD Return
−42.19%
RSI (14)
40.3
ValuationView details →
P/E (Fwd)
11.8x
EV/EBITDA
9.9x
Market Cap
$30.17B
RSI (14)
40.3
MomentumView details →
1D Return
+0.15%
YTD Return
−42.19%
SummaryUpdated Jun 1, 2026
Zoetis Inc. (NYSE:ZTS) is the world's largest animal health company, founded in 1952 and spun off from Pfizer in 2013 through an initial public offering. Headquartered in Parsippany, New Jersey, the company has evolved from a pharmaceutical division into an independent leader in veterinary medicine, serving both companion animals and livestock across global markets. With operations spanning the United States and international markets, Zoetis has established itself as a dominant force in animal healthcare through decades of scientific innovation and strategic market expansion.
Similar companies
Latest newsMore news →
The U.S. Food and Drug Administration published in the Federal Register three Emergency Use Authorizations for animal drugs to treat or prevent New World screwworm, including the first injectable product listing deer, issued to Zoetis, Felix Pharmaceuticals, and Alberta Vet Labs.10d agoZoetis received emergency use authorization for its drug to treat screwworm, causing its stock price to rise.30d agoZoetis Inc.'s stock price hit a new 52-week low during mid-day trading on Monday after Piper Sandler lowered its price target from $90.00 to $80.00.33d ago